Home

TIMOTHY C BARABE

CIK 1237409 · Chief Financial Officer · last filed 2026-07-24

TIMOTHY C BARABE is a Chief Financial Officer who has filed 270 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider exercised options covering $70.5K of HTFL on Jul 24, 2026. Across all open-market trades the lifetime net is −$3.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.62M

Companies

7

Total Filings

270

Lifetime Open-Market Net

-$3.29M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HTFL Director 188,231 $29.54 $5.56M $0 6 2026-07-24
RNAC Director 56,966 $8.59 $489.1K $301.0K 6 2026-01-06
Cartesian Therapeutics, Inc. (SELB) Delisted Director 250,013 $0.88 $220.3K $273.7K 20 2023-01-04
VEEV Director 6,643 $236.58 $1.57M -$1.35M 39 2021-06-23
Acer Therapeutics Inc. (OPXAW) Delisted Director 20,719 — — $3.3K 11 2016-11-22
AFFYMETRIX INC (AFFX) Delisted Chief Financial Officer 166,378 — — $337.8K 21 2013-03-20
HUMAN GENOME SCIENCES INC (HGSI) Delisted Chief Financial Officer 49,570 — — -$2.85M 16 2010-02-22

Recent Filings

270 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-24 HTFL Exer (M) +3,710 $70.5K EDGAR
2026-07-20 HTFL Exer (M) +5,000 $95.0K EDGAR
2026-06-18 HTFL Grant (A) — $0 EDGAR
2026-03-12 HTFL Exer (M) +8,667 $19.2K EDGAR
2026-02-19 HTFL Exer (M) +2,497 $20.8K EDGAR
2026-01-06 RNAC Grant (A) +2,600 $0 EDGAR
2025-12-08 RNAC Buy (P) +30,000 $205.8K EDGAR
2025-08-11 HTFL Mixed +131,578 $0 EDGAR
2025-01-06 RNAC Grant (A) +2,600 $0 EDGAR
2024-08-14 RNAC Buy (P) +7,500 $95.2K EDGAR
Showing 1–10 of 270
Page 1 of 27
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.